Protarga, Icos small molecule cancer deal

Protarga (King of Prussia, Penn.) and ICOS partnered to develop small molecule cancer compounds. Protarga will link ICOS's cell cycle checkpoint and DNA repair antagonist compounds to its Targaceutica...